Controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile1 entries
2026
TFDA orders recall of Biocor heart drug tablets over impurities
Recall announced
The Taiwan Food and Drug Administration ordered the recall of 586,000 tablets of Biocor Film-Coated Tablets 5 mg, supplied by Anxo Pharmaceutical Co. under batch number BCLA91. The order followed the supplier's report that impurity levels had reached the upper limit of specifications during recent stability testing, potentially affecting the drug's quality and efficacy. The company was required to complete the recall by Aug. 31 and to submit a recall report together with corrective and preventive measures.
Company response
Recall — Anxo Pharmaceutical Co.
The recall of Biocor Film-Coated Tablets 5 mg, supplied by Anxo Pharmaceutical Co. and bearing batch number BCLA91, was announced by the TFDA on Wednesday.
Source excerpt
The Taiwan Food and Drug Administration (TFDA) has ordered the recall of 586,000 tablets of a heart medication because of impurities that could potentially affect its efficacy.
Liu said the company was ordered to complete the recall by Aug. 31 and submit a recall report, along with corrective and preventive measures to avoid similar problems in the future.
The recall of Biocor Film-Coated Tablets 5 mg, supplied by Anxo Pharmaceutical Co. and bearing batch number BCLA91, was announced by the TFDA on Wednesday.